 | • レポートコード：MRC2-11QY06374 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は卵胞刺激ホルモン（FSH）のグローバル市場について調査・分析したレポートです。種類別（組換えFSH、尿中FSH）市場規模、用途別（不妊治療、生殖補助医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別卵胞刺激ホルモン（FSH）の競争状況、市場シェア ・世界の卵胞刺激ホルモン（FSH）市場：種類別市場規模 2015年-2020年（組換えFSH、尿中FSH） ・世界の卵胞刺激ホルモン（FSH）市場：種類別市場規模予測 2021年-2026年（組換えFSH、尿中FSH） ・世界の卵胞刺激ホルモン（FSH）市場：用途別市場規模 2015年-2020年（不妊治療、生殖補助医療） ・世界の卵胞刺激ホルモン（FSH）市場：用途別市場規模予測 2021年-2026年（不妊治療、生殖補助医療） ・北米の卵胞刺激ホルモン（FSH）市場分析：米国、カナダ ・ヨーロッパの卵胞刺激ホルモン（FSH）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの卵胞刺激ホルモン（FSH）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の卵胞刺激ホルモン（FSH）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの卵胞刺激ホルモン（FSH）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck Serono、MSD、IBSA、Ferring、Livzon、Techwell、GenSci ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Follicle-stimulating Hormone (FSH) Market
The global Follicle-stimulating Hormone (FSH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Follicle-stimulating Hormone (FSH) Scope and Market Size
Follicle-stimulating Hormone (FSH) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Follicle-stimulating Hormone (FSH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Follicle-stimulating Hormone (FSH) market is segmented into
Recombinant FSH
Urinary FSH
Segment by Application, the Follicle-stimulating Hormone (FSH) market is segmented into
Infertility Treatment
Assisted Reproductive Technology
Regional and Country-level Analysis
The Follicle-stimulating Hormone (FSH) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Follicle-stimulating Hormone (FSH) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Follicle-stimulating Hormone (FSH) Market Share Analysis
Follicle-stimulating Hormone (FSH) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Follicle-stimulating Hormone (FSH) business, the date to enter into the Follicle-stimulating Hormone (FSH) market, Follicle-stimulating Hormone (FSH) product introduction, recent developments, etc.
The major vendors covered:
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
…
1 Study Coverage
1.1 Follicle-stimulating Hormone (FSH) Product Introduction
1.2 Market Segments
1.3 Key Follicle-stimulating Hormone (FSH) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Follicle-stimulating Hormone (FSH) Market Size Growth Rate by Type
1.4.2 Recombinant FSH
1.4.3 Urinary FSH
1.5 Market by Application
1.5.1 Global Follicle-stimulating Hormone (FSH) Market Size Growth Rate by Application
1.5.2 Infertility Treatment
1.5.3 Assisted Reproductive Technology
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Follicle-stimulating Hormone (FSH) Market Size, Estimates and Forecasts
2.1.1 Global Follicle-stimulating Hormone (FSH) Revenue 2015-2026
2.1.2 Global Follicle-stimulating Hormone (FSH) Sales 2015-2026
2.2 Global Follicle-stimulating Hormone (FSH), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Follicle-stimulating Hormone (FSH) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Follicle-stimulating Hormone (FSH) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Follicle-stimulating Hormone (FSH) Competitor Landscape by Players
3.1 Follicle-stimulating Hormone (FSH) Sales by Manufacturers
3.1.1 Follicle-stimulating Hormone (FSH) Sales by Manufacturers (2015-2020)
3.1.2 Follicle-stimulating Hormone (FSH) Sales Market Share by Manufacturers (2015-2020)
3.2 Follicle-stimulating Hormone (FSH) Revenue by Manufacturers
3.2.1 Follicle-stimulating Hormone (FSH) Revenue by Manufacturers (2015-2020)
3.2.2 Follicle-stimulating Hormone (FSH) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Follicle-stimulating Hormone (FSH) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Follicle-stimulating Hormone (FSH) Revenue in 2019
3.2.5 Global Follicle-stimulating Hormone (FSH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Follicle-stimulating Hormone (FSH) Price by Manufacturers
3.4 Follicle-stimulating Hormone (FSH) Manufacturing Base Distribution, Product Types
3.4.1 Follicle-stimulating Hormone (FSH) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Follicle-stimulating Hormone (FSH) Product Type
3.4.3 Date of International Manufacturers Enter into Follicle-stimulating Hormone (FSH) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Follicle-stimulating Hormone (FSH) Market Size by Type (2015-2020)
4.1.1 Global Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020)
4.1.2 Global Follicle-stimulating Hormone (FSH) Revenue by Type (2015-2020)
4.1.3 Follicle-stimulating Hormone (FSH) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Follicle-stimulating Hormone (FSH) Market Size Forecast by Type (2021-2026)
4.2.1 Global Follicle-stimulating Hormone (FSH) Sales Forecast by Type (2021-2026)
4.2.2 Global Follicle-stimulating Hormone (FSH) Revenue Forecast by Type (2021-2026)
4.2.3 Follicle-stimulating Hormone (FSH) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Follicle-stimulating Hormone (FSH) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Follicle-stimulating Hormone (FSH) Market Size by Application (2015-2020)
5.1.1 Global Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020)
5.1.2 Global Follicle-stimulating Hormone (FSH) Revenue by Application (2015-2020)
5.1.3 Follicle-stimulating Hormone (FSH) Price by Application (2015-2020)
5.2 Follicle-stimulating Hormone (FSH) Market Size Forecast by Application (2021-2026)
5.2.1 Global Follicle-stimulating Hormone (FSH) Sales Forecast by Application (2021-2026)
5.2.2 Global Follicle-stimulating Hormone (FSH) Revenue Forecast by Application (2021-2026)
5.2.3 Global Follicle-stimulating Hormone (FSH) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Follicle-stimulating Hormone (FSH) by Country
6.1.1 North America Follicle-stimulating Hormone (FSH) Sales by Country
6.1.2 North America Follicle-stimulating Hormone (FSH) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Type
6.3 North America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Application
7 Europe
7.1 Europe Follicle-stimulating Hormone (FSH) by Country
7.1.1 Europe Follicle-stimulating Hormone (FSH) Sales by Country
7.1.2 Europe Follicle-stimulating Hormone (FSH) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Follicle-stimulating Hormone (FSH) Market Facts & Figures by Type
7.3 Europe Follicle-stimulating Hormone (FSH) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Follicle-stimulating Hormone (FSH) by Region
8.1.1 Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Region
8.1.2 Asia Pacific Follicle-stimulating Hormone (FSH) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Follicle-stimulating Hormone (FSH) Market Facts & Figures by Type
8.3 Asia Pacific Follicle-stimulating Hormone (FSH) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Follicle-stimulating Hormone (FSH) by Country
9.1.1 Latin America Follicle-stimulating Hormone (FSH) Sales by Country
9.1.2 Latin America Follicle-stimulating Hormone (FSH) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Type
9.3 Central & South America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Follicle-stimulating Hormone (FSH) by Country
10.1.1 Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Country
10.1.2 Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Follicle-stimulating Hormone (FSH) Market Facts & Figures by Type
10.3 Middle East and Africa Follicle-stimulating Hormone (FSH) Market Facts & Figures by Application
11 Company Profiles
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Description and Business Overview
11.1.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Serono Follicle-stimulating Hormone (FSH) Products Offered
11.1.5 Merck Serono Related Developments
11.2 MSD
11.2.1 MSD Corporation Information
11.2.2 MSD Description and Business Overview
11.2.3 MSD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 MSD Follicle-stimulating Hormone (FSH) Products Offered
11.2.5 MSD Related Developments
11.3 IBSA
11.3.1 IBSA Corporation Information
11.3.2 IBSA Description and Business Overview
11.3.3 IBSA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 IBSA Follicle-stimulating Hormone (FSH) Products Offered
11.3.5 IBSA Related Developments
11.4 Ferring
11.4.1 Ferring Corporation Information
11.4.2 Ferring Description and Business Overview
11.4.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ferring Follicle-stimulating Hormone (FSH) Products Offered
11.4.5 Ferring Related Developments
11.5 Livzon
11.5.1 Livzon Corporation Information
11.5.2 Livzon Description and Business Overview
11.5.3 Livzon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Livzon Follicle-stimulating Hormone (FSH) Products Offered
11.5.5 Livzon Related Developments
11.6 Techwell
11.6.1 Techwell Corporation Information
11.6.2 Techwell Description and Business Overview
11.6.3 Techwell Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Techwell Follicle-stimulating Hormone (FSH) Products Offered
11.6.5 Techwell Related Developments
11.7 GenSci
11.7.1 GenSci Corporation Information
11.7.2 GenSci Description and Business Overview
11.7.3 GenSci Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GenSci Follicle-stimulating Hormone (FSH) Products Offered
11.7.5 GenSci Related Developments
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Description and Business Overview
11.1.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Serono Follicle-stimulating Hormone (FSH) Products Offered
11.1.5 Merck Serono Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Follicle-stimulating Hormone (FSH) Market Estimates and Projections by Region
12.1.1 Global Follicle-stimulating Hormone (FSH) Sales Forecast by Regions 2021-2026
12.1.2 Global Follicle-stimulating Hormone (FSH) Revenue Forecast by Regions 2021-2026
12.2 North America Follicle-stimulating Hormone (FSH) Market Size Forecast (2021-2026)
12.2.1 North America: Follicle-stimulating Hormone (FSH) Sales Forecast (2021-2026)
12.2.2 North America: Follicle-stimulating Hormone (FSH) Revenue Forecast (2021-2026)
12.2.3 North America: Follicle-stimulating Hormone (FSH) Market Size Forecast by Country (2021-2026)
12.3 Europe Follicle-stimulating Hormone (FSH) Market Size Forecast (2021-2026)
12.3.1 Europe: Follicle-stimulating Hormone (FSH) Sales Forecast (2021-2026)
12.3.2 Europe: Follicle-stimulating Hormone (FSH) Revenue Forecast (2021-2026)
12.3.3 Europe: Follicle-stimulating Hormone (FSH) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Follicle-stimulating Hormone (FSH) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Follicle-stimulating Hormone (FSH) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Follicle-stimulating Hormone (FSH) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Follicle-stimulating Hormone (FSH) Market Size Forecast by Region (2021-2026)
12.5 Latin America Follicle-stimulating Hormone (FSH) Market Size Forecast (2021-2026)
12.5.1 Latin America: Follicle-stimulating Hormone (FSH) Sales Forecast (2021-2026)
12.5.2 Latin America: Follicle-stimulating Hormone (FSH) Revenue Forecast (2021-2026)
12.5.3 Latin America: Follicle-stimulating Hormone (FSH) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Follicle-stimulating Hormone (FSH) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Follicle-stimulating Hormone (FSH) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Follicle-stimulating Hormone (FSH) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Follicle-stimulating Hormone (FSH) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Follicle-stimulating Hormone (FSH) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Follicle-stimulating Hormone (FSH) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Follicle-stimulating Hormone (FSH) Market Segments
Table 2. Ranking of Global Top Follicle-stimulating Hormone (FSH) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Follicle-stimulating Hormone (FSH) Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Recombinant FSH
Table 5. Major Manufacturers of Urinary FSH
Table 6. Global Follicle-stimulating Hormone (FSH) Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Follicle-stimulating Hormone (FSH) Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Follicle-stimulating Hormone (FSH) Sales by Regions 2015-2020 (K Doses)
Table 9. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Regions (2015-2020)
Table 10. Global Follicle-stimulating Hormone (FSH) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Follicle-stimulating Hormone (FSH) Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Follicle-stimulating Hormone (FSH) Sales Share by Manufacturers (2015-2020)
Table 13. Global Follicle-stimulating Hormone (FSH) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Follicle-stimulating Hormone (FSH) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle-stimulating Hormone (FSH) as of 2019)
Table 15. Follicle-stimulating Hormone (FSH) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Follicle-stimulating Hormone (FSH) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Follicle-stimulating Hormone (FSH) Price (2015-2020) (USD/Dose)
Table 18. Follicle-stimulating Hormone (FSH) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Follicle-stimulating Hormone (FSH) Product Type
Table 20. Date of International Manufacturers Enter into Follicle-stimulating Hormone (FSH) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 23. Global Follicle-stimulating Hormone (FSH) Sales Share by Type (2015-2020)
Table 24. Global Follicle-stimulating Hormone (FSH) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Follicle-stimulating Hormone (FSH) Revenue Share by Type (2015-2020)
Table 26. Follicle-stimulating Hormone (FSH) Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 28. Global Follicle-stimulating Hormone (FSH) Sales Share by Application (2015-2020)
Table 29. North America Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)
Table 30. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)
Table 31. North America Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)
Table 33. North America Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 34. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Table 35. North America Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 36. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Table 37. Europe Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)
Table 38. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)
Table 39. Europe Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)
Table 41. Europe Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 42. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Table 43. Europe Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 44. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Table 53. Latin America Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Table 59. Latin America Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Table 69. Merck Serono Corporation Information
Table 70. Merck Serono Description and Major Businesses
Table 71. Merck Serono Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. Merck Serono Product
Table 73. Merck Serono Recent Development
Table 74. MSD Corporation Information
Table 75. MSD Description and Major Businesses
Table 76. MSD Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. MSD Product
Table 78. MSD Recent Development
Table 79. IBSA Corporation Information
Table 80. IBSA Description and Major Businesses
Table 81. IBSA Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. IBSA Product
Table 83. IBSA Recent Development
Table 84. Ferring Corporation Information
Table 85. Ferring Description and Major Businesses
Table 86. Ferring Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Ferring Product
Table 88. Ferring Recent Development
Table 89. Livzon Corporation Information
Table 90. Livzon Description and Major Businesses
Table 91. Livzon Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Livzon Product
Table 93. Livzon Recent Development
Table 94. Techwell Corporation Information
Table 95. Techwell Description and Major Businesses
Table 96. Techwell Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Techwell Product
Table 98. Techwell Recent Development
Table 99. GenSci Corporation Information
Table 100. GenSci Description and Major Businesses
Table 101. GenSci Follicle-stimulating Hormone (FSH) Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. GenSci Product
Table 103. GenSci Recent Development
Table 104. Global Follicle-stimulating Hormone (FSH) Sales Forecast by Regions (2021-2026) (K Doses)
Table 105. Global Follicle-stimulating Hormone (FSH) Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Follicle-stimulating Hormone (FSH) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Follicle-stimulating Hormone (FSH) Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Follicle-stimulating Hormone (FSH) Sales Forecast by Country (2021-2026) (K Doses)
Table 109. North America: Follicle-stimulating Hormone (FSH) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Follicle-stimulating Hormone (FSH) Sales Forecast by Country (2021-2026) (K Doses)
Table 111. Europe: Follicle-stimulating Hormone (FSH) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Follicle-stimulating Hormone (FSH) Sales Forecast by Region (2021-2026) (K Doses)
Table 113. Asia Pacific: Follicle-stimulating Hormone (FSH) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Follicle-stimulating Hormone (FSH) Sales Forecast by Country (2021-2026) (K Doses)
Table 115. Latin America: Follicle-stimulating Hormone (FSH) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Follicle-stimulating Hormone (FSH) Sales Forecast by Country (2021-2026) (K Doses)
Table 117. Middle East and Africa: Follicle-stimulating Hormone (FSH) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Follicle-stimulating Hormone (FSH) Players
Table 122. Follicle-stimulating Hormone (FSH) Customers List
Table 123. Follicle-stimulating Hormone (FSH) Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicle-stimulating Hormone (FSH) Product Picture
Figure 2. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant FSH Product Picture
Figure 4. Urinary FSH Product Picture
Figure 5. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application in 2020 & 2026
Figure 6. Infertility Treatment
Figure 7. Assisted Reproductive Technology
Figure 8. Follicle-stimulating Hormone (FSH) Report Years Considered
Figure 9. Global Follicle-stimulating Hormone (FSH) Market Size 2015-2026 (US$ Million)
Figure 10. Global Follicle-stimulating Hormone (FSH) Sales 2015-2026 (K Doses)
Figure 11. Global Follicle-stimulating Hormone (FSH) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Region (2015-2020)
Figure 13. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Region in 2019
Figure 14. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Region (2015-2020)
Figure 15. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Region in 2019
Figure 16. Global Follicle-stimulating Hormone (FSH) Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Follicle-stimulating Hormone (FSH) Revenue in 2019
Figure 18. Follicle-stimulating Hormone (FSH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)
Figure 20. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Type in 2019
Figure 21. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Type (2015-2020)
Figure 22. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Type in 2019
Figure 23. Global Follicle-stimulating Hormone (FSH) Market Share by Price Range (2015-2020)
Figure 24. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)
Figure 25. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application in 2019
Figure 26. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Application (2015-2020)
Figure 27. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Application in 2019
Figure 28. North America Follicle-stimulating Hormone (FSH) Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Follicle-stimulating Hormone (FSH) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019
Figure 31. North America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019
Figure 32. U.S. Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Follicle-stimulating Hormone (FSH) Market Share by Type in 2019
Figure 37. North America Follicle-stimulating Hormone (FSH) Market Share by Application in 2019
Figure 38. Europe Follicle-stimulating Hormone (FSH) Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Follicle-stimulating Hormone (FSH) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019
Figure 41. Europe Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019
Figure 42. Germany Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Follicle-stimulating Hormone (FSH) Market Share by Type in 2019
Figure 53. Europe Follicle-stimulating Hormone (FSH) Market Share by Application in 2019
Figure 54. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Region in 2019
Figure 57. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Market Share by Region in 2019
Figure 58. China Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Follicle-stimulating Hormone (FSH) Market Share by Type in 2019
Figure 81. Asia Pacific Follicle-stimulating Hormone (FSH) Market Share by Application in 2019
Figure 82. Latin America Follicle-stimulating Hormone (FSH) Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Follicle-stimulating Hormone (FSH) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019
Figure 85. Latin America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019
Figure 86. Mexico Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Follicle-stimulating Hormone (FSH) Market Share by Type in 2019
Figure 93. Latin America Follicle-stimulating Hormone (FSH) Market Share by Application in 2019
Figure 94. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019
Figure 98. Turkey Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Follicle-stimulating Hormone (FSH) Market Share by Type in 2019
Figure 105. Middle East and Africa Follicle-stimulating Hormone (FSH) Market Share by Application in 2019
Figure 106. North America Follicle-stimulating Hormone (FSH) Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 107. North America Follicle-stimulating Hormone (FSH) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Follicle-stimulating Hormone (FSH) Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. Europe Follicle-stimulating Hormone (FSH) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Follicle-stimulating Hormone (FSH) Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Latin America Follicle-stimulating Hormone (FSH) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
メラノサイト刺激ホルモン受容体の世界市場（～2026年） Market Analysis and Insights: Global Melanocyte Stimulating Hormone Receptor Market The global Melanocyte Stimulating Hormone Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Melanocyte Stimulating Hormone Rece…- 成長ホルモン欠乏症治療の世界市場（～2026年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
- ヒト成長ホルモン（hGH）の世界市場（～2026年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 顆粒球マクロファージコロニー刺激因子の世界市場（～2026年） Market Analysis and Insights: Global Granulocyte Macrophage Colony Stimulating Factor Market The global Granulocyte Macrophage Colony Stimulating Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Granulocyte Macro…